OUR CLINICAL TRIALS

  • Status

  • Scenario

  • Patients population

  • Phase

  • Solti Program

  • Sites

  • Search

  • Reset


NOAH
Neoadjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer: a randomized phase III trial Leer mas
OLYMPIA
A randomised, double-blind, parallel group, placebo-controlled multi-centre, phase III study to assess the efficacy and Leer mas
ONAWA
A Window of Opportunity Trial of Onapristone as Preoperative Treatment for Postmenopausal Women with Hormone Leer mas
OPTI-HER-HEART (SOLTI-1002)
A prospective, multicenter, single-arm, phase II study to evaluate the safety of neoadjuvant liposomal doxorubicin Leer mas
PALLAS
A randomized phase III trial of Palbociclib with adjuvant endocrine therapy versus endocrine therapy alone Leer mas
PAMELA
PAM50 HER2-enriched phenotype as a predictor of early response to neoadjuvant lapatinib plus trastuzumab in Leer mas
PATINA
A Randomized, Open Label, Phase III Trial to Evaluate the Efficacy and Safety of Palbociclib Leer mas
SOLTI-1303 PATRICIA
A phase II study of palbociclib and trastuzumab with or without letrozole in previously treated, Leer mas
PATRICIA II – cohort PATRICIA trial
PATRICIAII was designed to include only patients with HR+/HER2+, PAM50 LuminalA/B tumors to receive palbociclib, Leer mas